urological cancers
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Any urological malignancy who need systemic therapy/molecular-targeting therapy/hormonal therapy/immunotherapy
Exclusion criteria
Exclusion criteria: History of severe cardiac conditions, such as angina requiring certain treatment with nitrates, unstable angina defined for study, positive cardiac stress test before starting the study. History of significant central nervous system (CNS) injuries (including stroke or spinal cord injury) within 6 months of Visit 1. History of drug, alcohol, or substance abuse within the 6 months before Visit 1. Have any condition, limitation, or disease that could, in the judgment of the investigator, preclude evaluation of response to therapy and QoL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of systemic chemotherapy, hormonal therapy and immunotherapy on onclogical outcomes | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of systemic chemotherapy, hormonal therapy and immunotherapy on patient reported outcomes in urological cancers | — |
Countries
Japan
Contacts
Hirosaki University School of Medicine Urology